Dinesh Kannabhiran1, John Lee, Joseph E Schwartz, Rex Friedlander, Meredith Aull, Thangamani Muthukumar, Sean Campbell, David Epstein, Surya V Seshan, Sandip Kapur, Vijay K Sharma, Manikkam Suthanthiran, Darshana Dadhania. 1. 1 Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian-Weill Cornell Medical Center, New York, NY. 2 Department of Transplantation, OSF Saint Francis Medical Center, Peroria, IL. 3 Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY. 4 Department of Psychiatry and Behavioral Sciences, Stony Brook University, Stony Brook, NY. 5 Department of Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY. 6 Department of Pathology, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY.
Abstract
BACKGROUND: Characteristics of pretransplant antibodies directed at donor human leukocyte antigen (HLA) donor-specific antibodies (DSA) associated with adverse outcomes in kidney transplant recipients are being elucidated but uncertainties exist. METHODS: We prospectively screened pretransplant sera from 543 kidney recipients using single antigen bead assays and identified 154 patients with and 389 without DSA. We investigated the association of DSA features to acute rejection and graft failure. RESULTS: One-year acute rejection incidence was higher in DSA-positive group (P < 0.001), primarily due to antibody-mediated rejection (AMR, 13% vs. 1.8%, P < 0.001) and not T cell-mediated rejection (ACR, 5% vs.6%, P = 0.65). The sum of mean fluorescence intensity of DSA (DSA MFI-Sum) of 6,000 or higher (OR, 18; 95% CI, 7.0-47; P < 0.001) and the presence of DSA against both HLA class I and II (OR, 39; 95% CI, 14-106; P < 0.0001) predicted 1-year AMR, independent of other covariates. Calculated panel reactive antibody and a positive flow cytometry cross-match result were associated with AMR by bivariate analysis but neither was an independent predictor in a multivariable regression analysis that included DSA-MFI-Sum or HLA DSA class. In multivariable Cox proportional hazards models, the covariate-adjusted hazard ratio for graft failure was 2.03 (95%CI, 1.05-3.92; P = 0.04) for DSA MFI-Sum of 6,000 or higher and 2.23 (95% CI, 1.04-4.80; P = 0.04) for class I and II DSA. Prediction of graft failure was not independent of AMR. CONCLUSION: Our study suggests that DSA MFI-Sum and HLA class of DSA are characteristics predictive of AMR and graft failure. The elevated risk of graft failure in those with the identified features of DSA is attributable to increased risk of AMR.
BACKGROUND: Characteristics of pretransplant antibodies directed at donorhuman leukocyte antigen (HLA) donor-specific antibodies (DSA) associated with adverse outcomes in kidney transplant recipients are being elucidated but uncertainties exist. METHODS: We prospectively screened pretransplant sera from 543 kidney recipients using single antigen bead assays and identified 154 patients with and 389 without DSA. We investigated the association of DSA features to acute rejection and graft failure. RESULTS: One-year acute rejection incidence was higher in DSA-positive group (P < 0.001), primarily due to antibody-mediated rejection (AMR, 13% vs. 1.8%, P < 0.001) and not T cell-mediated rejection (ACR, 5% vs.6%, P = 0.65). The sum of mean fluorescence intensity of DSA (DSA MFI-Sum) of 6,000 or higher (OR, 18; 95% CI, 7.0-47; P < 0.001) and the presence of DSA against both HLA class I and II (OR, 39; 95% CI, 14-106; P < 0.0001) predicted 1-year AMR, independent of other covariates. Calculated panel reactive antibody and a positive flow cytometry cross-match result were associated with AMR by bivariate analysis but neither was an independent predictor in a multivariable regression analysis that included DSA-MFI-Sum or HLA DSA class. In multivariable Cox proportional hazards models, the covariate-adjusted hazard ratio for graft failure was 2.03 (95%CI, 1.05-3.92; P = 0.04) for DSA MFI-Sum of 6,000 or higher and 2.23 (95% CI, 1.04-4.80; P = 0.04) for class I and II DSA. Prediction of graft failure was not independent of AMR. CONCLUSION: Our study suggests that DSA MFI-Sum and HLA class of DSA are characteristics predictive of AMR and graft failure. The elevated risk of graft failure in those with the identified features of DSA is attributable to increased risk of AMR.
Authors: Julie M Yabu; John P Higgins; Ge Chen; Flavia Sequeira; Stephan Busque; Dolly B Tyan Journal: Transplantation Date: 2011-02-15 Impact factor: 4.939
Authors: Neeraj Singh; Arjang Djamali; David Lorentzen; John D Pirsch; Glen Leverson; Nikole Neidlinger; Barbara Voss; Jose R Torrealba; R Michael Hofmann; Jon Odorico; Luis A Fernandez; Hans W Sollinger; Milagros Samaniego Journal: Transplantation Date: 2010-11-27 Impact factor: 4.939
Authors: Elaine Y Cheng; Matthew J Everly; Hugo Kaneku; Nubia Banuelos; Laura J Wozniak; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Ronald W Busuttil; Paul I Terasaki; Douglas G Farmer Journal: Transplantation Date: 2017-04 Impact factor: 4.939
Authors: Carrie A Schinstock; Andrew J Bentall; Byron H Smith; Lynn D Cornell; Matthew Everly; Manish J Gandhi; Mark D Stegall Journal: Am J Transplant Date: 2018-12-15 Impact factor: 8.086
Authors: Carrie A Schinstock; Darshana M Dadhania; Matthew J Everly; Byron Smith; Manish Gandhi; Evan Farkash; Vijay K Sharma; Milagros Samaniego-Picota; Mark D Stegall Journal: Transpl Int Date: 2019-02-08 Impact factor: 3.782
Authors: Nicole Wittenbrink; Sabrina Herrmann; Arturo Blazquez-Navarro; Chris Bauer; Eric Lindberg; Kerstin Wolk; Robert Sabat; Petra Reinke; Birgit Sawitzki; Oliver Thomusch; Christian Hugo; Nina Babel; Harald Seitz; Michal Or-Guil Journal: BMC Immunol Date: 2019-04-27 Impact factor: 3.615
Authors: Audrey Uffing; Luis G Hidalgo; Ciaran McMullan; Jacqueline Perry; Edgar L Milford; Naoka Murakami; Melissa Y Yeung; Indira Guleria; Isabelle G Wood; Enver Akalin; Jamil Azzi; Anil K Chandraker; Leonardo V Riella Journal: Transplant Direct Date: 2019-04-15
Authors: Alexander H Morrison; Meera Gupta; Kelsey Lloyd; Jennifer Trofe-Clark; Mary Ann Lim; Christine Limonte; Matthew H Levine; Deirdre Sawinski; Malek Kamoun; Paige M Porrett Journal: Transplant Direct Date: 2019-07-25
Authors: Ana Navas; Juan Molina; María-Luisa Agüera; Ipek Guler; Aurora Jurado; Alberto Rodríguez-Benot; Corona Alonso; Rafael Solana Journal: Front Immunol Date: 2019-08-02 Impact factor: 7.561